BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8633185)

  • 1. Biological variation in bone-derived biochemical markers in serum.
    Panteghini M; Pagani F
    Scand J Clin Lab Invest; 1995 Nov; 55(7):609-16. PubMed ID: 8633185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of bone turnover: biochemical and clinical perspectives.
    Pagani F; Francucci CM; Moro L
    J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term variability in biomarkers of bone metabolism in sheep.
    Sousa CP; de Azevedo JT; Reis RL; Gomes ME; Dias IR
    Lab Anim (NY); 2014 Jan; 43(1):21-6. PubMed ID: 24356018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference intervals for two bone-derived enzyme activities in serum: bone isoenzyme of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TR-ACP).
    Panteghini M; Pagani F
    Clin Chem; 1989 Jan; 35(1):180-1. PubMed ID: 2910567
    [No Abstract]   [Full Text] [Related]  

  • 6. Do serological tissue turnover markers represent callus formation during fracture healing?
    Seebeck P; Bail HJ; Exner C; Schell H; Michel R; Amthauer H; Bragulla H; Duda GN
    Bone; 2005 Nov; 37(5):669-77. PubMed ID: 16126014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover and their relation to forearm bone mineral density in persons of Pakistani and Norwegian background living in Oslo, Norway: The Oslo Health Study.
    Holvik K; Meyer HE; Søgaard AJ; Selmer R; Haug E; Falch JA
    Eur J Endocrinol; 2006 Nov; 155(5):693-9. PubMed ID: 17062885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical markers for bone metabolism--overview].
    Nakatsuka K; Nishizawa Y
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():220-7. PubMed ID: 11979911
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma.
    Desoize B; Amico S; Larbre H; Coninx P; Jardillier JC
    Clin Biochem; 1991 Oct; 24(5):443-6. PubMed ID: 1760884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats.
    Shao P; Ohtsuka-Isoya M; Shinoda H
    Chronobiol Int; 2003 Mar; 20(2):325-36. PubMed ID: 12723888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ; Presl J; Broulík P; Pacovský V
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age on some blood variables relating to bone metabolism in women.
    Willig R; Jalovaara P
    Int J Surg Investig; 2000; 1(6):495-502. PubMed ID: 11729857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased bone resorption and decreased bone formation in Chinese patients with hip fracture.
    Cheung CK; Panesar NS; Lau E; Woo J; Swaminathan R
    Calcif Tissue Int; 1995 May; 56(5):347-9. PubMed ID: 7621338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and its considerable role in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in postmenopausal women.
    Mysliwiec J; Adamczyk M; Nikolajuk A; Gorska M
    Endokrynol Pol; 2011; 62(4):299-302. PubMed ID: 21879468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age and sex on osteocalcin and bone-specific alkaline phosphatase-reference intervals and confounders for two bone formation markers.
    Diemar SS; Møllehave LT; Quardon N; Lylloff L; Thuesen BH; Linneberg A; Jørgensen NR
    Arch Osteoporos; 2020 Feb; 15(1):26. PubMed ID: 32095898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents.
    Magnusson P; Häger A; Larsson L
    Pediatr Res; 1995 Dec; 38(6):955-61. PubMed ID: 8618800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 is not essential for bone turnover in hypothyroid mice.
    Mysliwiec J; Zbucki R; Winnicka M; Sawicki B; Nikolajuk A; Kaminski K; Mysliwiec P; Musial W; Bondyra Z; Walecki J; Gorska M
    Folia Histochem Cytobiol; 2007; 45(4):387-92. PubMed ID: 18165179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.